Article
[Homozygous and compound heterozygous RYR1 mutations. New findings on prevalence and penetrance of malignant hyperthermia].
Der Anaesthesist - 1 Sept 2014
Wolak S, Rücker B, Kohlschmidt N, Doetsch S, Bartsch O, Zechner U, Tzanova I
Abstract excerpt
BACKGROUND: Malignant hyperthermia (MH) is a life-threatening, acute pharmacogenetic disorder mostly due to heterozygous mutations in the ryanodin receptor 1 (RYR1) gene. Diagnosis is generally confirmed by the in vitro contracture test (IVCT). In this study the genotype-phenotype correlation was analyzed and the presumed prevalence of MH is discussed. PATIENTS AND METHODS: After the diagnosis of MH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
